Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 9
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
HER2 / ERBB2 expression
gastric cancer · Small Molecule Inhibitor
HER2 / ERBB2 expression is flagged as manual review required because public trials show inclusion required evidence in 11 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 5
Common snippets: MSI-H | MSI-H | MSI-H
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT06364410 | https://clinicaltrials.gov/study/NCT05218148 | https://clinicaltrials.gov/study/NCT07511894 | https://clinicaltrials.gov/study/NCT06967987 | https://clinicaltrials.gov/study/NCT07621562 | https://clinicaltrials.gov/study/NCT07692334 | https://clinicaltrials.gov/study/NCT02344810 | https://clinicaltrials.gov/study/NCT06346197 | https://clinicaltrials.gov/study/NCT06222944 | https://clinicaltrials.gov/study/NCT06093425 | https://clinicaltrials.gov/study/NCT05482893